Author:
Ding Yibo,Chen Min,Wang Jibao,Yang Yuecheng,Feng Yi,Wang Lijie,Duan Song,Lin Qianru,Xing Hui,Ma Yanling,Han Mengjie,Ma Liying
Abstract
Abstract
Background
HIV-transmitted drug resistance (TDR) is found in antiretroviral therapy (ART)-naïve populations infected with HIV-1 with TDR mutations and is important for guiding future first- and second-line ART regimens. We investigated TDR and its effect on CD4 count in ART-naïve youths from the China-Myanmar border near the Golden Triangle to better understand TDR and effectively guide ART.
Methods
From 2009 to 2017, 10,832 HIV-1 infected individuals were newly reported along the Dehong border of China, 573 ART-naïve youths (16 ~ 25 y) were enrolled. CD4 counts were obtained from whole blood samples. HIV pol gene sequences were amplified from RNA extracted from plasma. The Stanford REGA program and jpHMM recombination prediction tool were used to determine genotypes. TDR mutations (TDRMs) were analyzed using the Stanford Calibrated Population Resistance tool.
Results
The most common infection route was heterosexuals (70.51%), followed by people who inject drugs (PWID, 19.20%) and men who have sex with men (MSM) (8.90%). The distribution of HIV genotypes mainly included the unique recombinant form (URF) (44.08%), 38.68% were CRFs, 13.24% were subtype C and 4.04% were subtype B. The prevalence of TDR increased significantly from 2009 to 2017 (3.48 to 9.48%) in ART-naïve youths (4.00 to 13.16% in Burmese subjects, 3.33 to 5.93% in Chinese subjects), and the resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs), nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs), and protease inhibitors (PIs) were 3.49, 2.62, and 0.52%, respectively. Most (94.40%, n = 34) of HIV-1-infected patients with TDRM had mutation that conferred resistance to a single drug class. The most common mutations Y181I/C and K103N, were found in 7 and 9 youths, respectively. The mean CD4 count was significantly lower among individuals with TDRMs (373/mm3 vs. 496/mm3, p = 0.013).
Conclusions
The increase in the prevalence of HIV-1 TDR increase and a low CD4 count of patients with TDRMs in the China-Myanmar border suggests the need for considering drug resistance before initiating ART in HIV recombination hotspots.
Funder
National Science and Technology Major Project
National Natural Science Foundation of China
National Major Project of the State Key Laboratory of Infectious Diseases Prevention and Control
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Latest global and regional statistics on the status of the AIDS epidemic. [https://www.unaids.org/en/resources/documents/2019/UNAIDS_FactSheet].
2. HIV drug resistance report 2019 [https://apps.who.int/iris/handle/10665/325891].
3. Ye J, Hao M, Xing H, Zhang F, Wu H, Lv W, Jiang T, Wang Y, Wang J, Feng Y, et al. Transmitted HIV drug resistance among individuals with newly diagnosed HIV infection: a multicenter observational study. AIDS. 2019.
4. Yang LIJZ, Yi FENG, Hongyan LU. Zang xihui, Xu xiaoqin, Yang Jiezhe: gene characteristic and transmitted drug resistance of HIV-1 strains among infected patientsat the age of 16-25 years in China. China J AIDS STD. 2017;23(03):176–80.
5. Chen M, Zhu Q, Xing H, Chen H, Jin X, Dong L, Dai J, Yang M, Yang C, Jia M, et al. The characteristics of pretreatment HIV-1 drug resistance in western Yunnan, China. Epidemiol Infect. 2020;148:e102.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献